Reduced Mortality Associated With the Use of Metformin Among Patients With Autoimmune Diseases

OBJECTIVE: Metformin has been linked to anti-proliferative and anti-inflammatory mechanisms. In this study, we aimed to examine the long-term impact of metformin on mortality and organ damage in patients with autoimmune diseases and type 2 diabetes mellitus (T2DM). METHODS: We conducted a cohort stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chun-Yu, Wu, Chun-Hsin, Hsu, Chung-Yuan, Chen, Tien-Hsing, Lin, Ming-Shyan, Lin, Yu-Sheng, Su, Yu-Jih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104028/
https://www.ncbi.nlm.nih.gov/pubmed/33967957
http://dx.doi.org/10.3389/fendo.2021.641635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104028/
https://www.ncbi.nlm.nih.gov/pubmed/33967957
http://dx.doi.org/10.3389/fendo.2021.641635

Ejemplares similares